1
|
Boord MS, Brown P, Soriano J, Meola T, Dumuid D, Milte R, Roughead EE, Lovell NH, Stone H, Whitehouse J, Janetzki JL, Gebreyohannes EA, Lim R. A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility study. BMJ Open 2024; 14:e080148. [PMID: 38341209 PMCID: PMC10862280 DOI: 10.1136/bmjopen-2023-080148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Accepted: 01/30/2024] [Indexed: 02/12/2024] Open
Abstract
INTRODUCTION This feasibility study aims to develop and test a new model of practice in Australia using digital technologies to enable pharmacists to monitor early signs and symptoms of medicine-induced harms in residential aged care. METHODS AND ANALYSIS Thirty residents will be recruited from an aged care facility in South Australia. The study will be conducted in two phases. In phase I, the study team will work with aged care software providers and developers of digital technologies (a wearable activity tracker and a sleep tracking sensor) to gather physical activity and sleep data, as well as medication and clinical data from the electronic medication management system and aged care clinical software. Data will be centralised into a cloud-based monitoring platform (TeleClinical Care (TCC)). The TCC will be used to create dashboards that will include longitudinal visualisations of changes in residents' health, function and medicine use over time. In phase II, the on-site pharmacist will use the centralised TCC platform to monitor each resident's medicine, clinical, physical activity and sleep data to identify signs of medicine-induced harms over a 12-week period.A mixed methods process evaluation applying the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) evaluation framework will be used to assess the feasibility of the service. Outcome measures include service reach, changes in resident symptom scores (measured using the Edmonton Symptom Assessment System), number of medication adverse events detected, changes in physical activity and sleep, number of pharmacist recommendations provided, cost analysis and proportion of all pharmacists' recommendations implemented at 4-week, 8-week and 12-week postbaseline period. ETHICS AND DISSEMINATION Ethical approval has been obtained from the University of South Australia's Human Research Ethics Committee (205098). Findings will be disseminated through published manuscripts, conference presentations and reporting to the study funder. TRIAL REGISTRATION NUMBER ACTRN12623000506695.
Collapse
Affiliation(s)
- Monique S Boord
- Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia
| | - Peter Brown
- Tyree Foundation Institute of Health Engineering (IHealthE) and Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia
| | - Julian Soriano
- Tanunda Lutheran Home Inc, Tanunda, South Australia, Australia
- SA Pharmacy, Adelaide, South Australia, Australia
| | - Tahlia Meola
- UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
| | - Dorothea Dumuid
- Alliance for Research in Exercise, Nutrition and Activity, University of South Australia, Adelaide, South Australia, Australia
| | - Rachel Milte
- Rehabilitation, Aged and Extended Care, Flinders University, Adelaide, South Australia, Australia
| | - Elizabeth E Roughead
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
| | - Nigel H Lovell
- Tyree Foundation Institute of Health Engineering (IHealthE) and Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia
| | - Helen Stone
- Pharmaceutical Society of Australia, Deakin, Australian Capital Territory, Australia
| | | | - Jack L Janetzki
- Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia
- UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
| | - Eyob Alemayehu Gebreyohannes
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
- School of Allied Health, The University of Western Australia, Perth, Western Australia, Australia
| | - Renly Lim
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
| |
Collapse
|
2
|
Tamargo M, Gutierrez E, Vazquez ME, Sanz-Ruiz R, Diez-Delhoyo F, Soriano J, Elizaga J, Fernandez-Aviles F. Experience of the combined use of the cusp-overlap projection and auricular pacing in transcatheter aortic-valve replacement with the self-expanding valves. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Need of permanent pacemaker implantation (PPI) continues to be an undesirable side-effect after transcatheter aortic-valve replacement (TAVR), mostly in self-expandable (SE) valves. Recently, different techniques have arisen, as the cusp-overlap projection (COP) to better control TAVR implantation depth, and the sequential atrial pacing (AP) after deployment to test atrioventricular (AV) conduction. However, the combination of both techniques has not been tested yet. We sought to determine if the combination of COP and AP can decrease the need of PPI after SE aortic prothesis.
Methods
We retrospectively studied 253 patients in sinus rhythm who underwent TAVR procedure with SE valves between 2018 and 2021, and compared standard implantation (n=143) with the combined use of COP and AP (n=110). Patients with permanent atrial fibrillation or previous pacemaker were excluded. Assessment included EKG, imaging, immediate and 30-day follow-up. AP was performed after TAVR in the absence of complete AV block at rates of 70 to 120 beats/min (or until AV Block was observed).
Results
Median patient age was 80 [75–85] years old and 52.2% were female. No significant differences could be appreciated in baseline demographics or treatment. Both cohorts had similar EKG intervals and similar rates of conduction disturbances (Table 1). Patients with CO+AP displayed bigger outflow tract perimeters (p=0.003). Also, the CO+AP cohort underwent more frequent predilation prior to valve deployment (p<0.001).
During TAVR complete AV block occurred in 4.6% of the CO+AP cohort vs 14.8% in the standard group (p=0.002). Among patients with transient or no conduction disturbances immediately after deployment, AP showed Wenckebach phenomenon in 22 subjects at a median heart rate of 110 bpm. PPI was considered within 24 hours when Wenckebach phenomenon developed below 90 bpm. Testing atrio-his conduction led to a significant decrease in the next 24-hour surveillance with a temporary pacemaker in the COP+AP cohort (23.1% vs 90.2% in the standard cohort, p<0.0001). Time of hospitalization was significantly reduce in the COP + AP cohort (mean stay 2 [1; 3] days vs 5 [4; 8] days in the standard cohort, p<0.0001), and the total amount of total PPI at that time was still lower CO+AP group (12.7% in CO+AP group vs 21.0% in the standard, p=0.121) (Figure 1).
On a 30-day follow-up, the rate of PPI after TAVR remained significantly decreased in the COP+AP cohort (p=0.039, Figure 1).
Conclusion
Combining COP with AP reduces the need of immediate and short-term PPI and reducing on-admission conduction surveillance and hospitalization stay after self-expandable TAVR.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Tamargo
- University Hospital Gregorio Maranon , Madrid , Spain
| | - E Gutierrez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - M E Vazquez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - R Sanz-Ruiz
- University Hospital Gregorio Maranon , Madrid , Spain
| | | | - J Soriano
- University Hospital Gregorio Maranon , Madrid , Spain
| | - J Elizaga
- University Hospital Gregorio Maranon , Madrid , Spain
| | | |
Collapse
|
3
|
Tamargo M, Garcia-Carreno J, Gutierrez E, Vazquez ME, Sanz-Ruiz R, Diez-Delhoyo F, Blazquez Z, Castrodeza J, Soriano J, Alonso A, Zatarain E, Arenal A, Elizaga J, Fernandez-Aviles F. Early results of a simplified protocol over standard in patients undergoing transcatheter aortic-valve replacement. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Transcatheter aortic-valve replacement (TAVR) procedure has been simplified, being now a less-invasive minimalist strategy the standard of treatment. Therefore, length of hospitalization has decreased, and early-discharge (ED) (<72 hour) protocols are in development.
Lately, additional techniques to optimize TAVR procedure have arisen, such as the use of radial approach as the secondary access, conscious sedation, cusp overlap projection (COP) to better control the implantation depth in self-expanding (SE) valves, or atrial pacing (AP) after deployment to test atrioventricular (AV) conduction. With the combination of these 4 maneuvers, we have developed an ED protocol, and hereby present the immediate results.
Methods
We prospectively studied 176 patients who underwent staged and transfemoral TAVR procedure with our novel protocol between May 2020 and December 2021 (Protocol) and compared them with a retrospective cohort of 175 patients who underwent standard TAVR between January 2018 and April 2020 (Standard). The protocol cohort included the use of conscious sedation with midazolam and fentanyl, routine radial approach as the secondary access, use of the CO projection, and AP after deployment in the absence of complete AV block, at rates of 70 to 120 beats/min (or until AV Block was observed) in 10 beats/min increments for a total of 20 beats at each increment. As part of this protocol, patients remained in general cardiology ward, avoiding ICU stay, with rapid recovery and early mobilization (After 6 hours in the absence of bleeding). In the absence of complications patients were discharged within 24–48 hours and reviewed a week and a month later in clinic. Initial assessment included EKG, echocardiogram, in hospital and 30-day follow-up.
Results
Median patient age was 80 years old and 49.9% were female. Despite higher rates of hypertension in the standard cohort (p=0.038), no significant differences could be appreciated in baseline demographics, EKG or imaging findings (Table).
Even with higher rates of predilation, CO and AP, the length of procedure and the use of contrast was lower in the protocol cohort. Rates of intraprocedural AV block were similar among groups (p=p.21), but AP led to a significant lower need of temporary pacemaker surveillance (p<0.0001). The use of radial access also tend to diminish immediate bleeding and vascular complications.
According to protocol, the median length of stay was reduced to 2 [1; 4] days (p<0.0001).
At a 30-day follow up, the incidence of major adverse cardiac events was low and similar among groups (p=0.67) (Figure), with no significant differences in the incidence of permanent pacemaker implantation, heart failure admission, bleeding o vascular complication (Figure)
Conclusion
A simplified TAVR protocol combining radial access, CO, AP can be adopted safely, leading to TAVR patients early discharge, with no major events on an immediate 30-day follow-up.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Tamargo
- University Hospital Gregorio Maranon , Madrid , Spain
| | | | - E Gutierrez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - M E Vazquez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - R Sanz-Ruiz
- University Hospital Gregorio Maranon , Madrid , Spain
| | | | - Z Blazquez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - J Castrodeza
- University Hospital Gregorio Maranon , Madrid , Spain
| | - J Soriano
- University Hospital Gregorio Maranon , Madrid , Spain
| | - A Alonso
- University Hospital Gregorio Maranon , Madrid , Spain
| | - E Zatarain
- University Hospital Gregorio Maranon , Madrid , Spain
| | - A Arenal
- University Hospital Gregorio Maranon , Madrid , Spain
| | - J Elizaga
- University Hospital Gregorio Maranon , Madrid , Spain
| | | |
Collapse
|
4
|
Tamargo M, Gutierrez E, Vazquez ME, Sanz-Ruiz R, Diez-Delhoyo F, Soriano J, Elizaga J, Fernandez-Aviles F. Transcatheter aortic-valve replacement with the self-expanding valve Portico in low-risk patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
In the past years, transcatheter aortic-valve replacement (TAVR) has risen as a feasible and safe option for patients with aortic stenosis, been now an option of treatment in low-risk (Euroscore II <4%) patients over 75 years.1
Evidence of this treatment with self-expandable supraanular bioprothesis Evolut have widely proven to be no inferior to surgical valve replacement.2 Nevertheless, experience of the annular self-expandable prothesis Portico available in this population is scarce.
Purpose
We present our early experience with the annular self-expandable prothesis Portico in our low-risk population.
Methods
We retrospectively studied 219 symptomatic low-risk patients with who underwent TAVR procedure with self-expandable valves between 2018 and 2021. Assessment included echocardiogram, immediate and 30-day follow-up, as well as last clinical visit follow-up. 92 subjects received an annular Portico prothesis. Our reference group was the suprannular prothesis Evolut (n=127), already validated for low-risk patients in clinical trials.2
Results
The mean age of the patients was 79 years, 43.4% were women, and all the patients were at low surgical risk (2.2 [1.6; 3.0]). No significant differences could be appreciated in baseline demographics and echocardiographic characteristics except for body mass index (BMI), which was higher in the Portico group (p<0.001) (Table).
Procedure length was similar, with the particular need of higher predilation in the Portico group according to recommendations. Both self-expandable prothesis had similar rates of intraprocedural atrioventricular block, bleeding, vascular complications, stroke, and new onset atrial fibrillation.
Mean aortic-valve gradients before discharge were lower at the suprannular Evolut group than in the annular Portico group, and immediate residual aortic regurgitation was almost inexistent in both groups (Table 1).
At a 30-day follow up, the incidence of major adverse cardiac events was low and similar among groups (p=0.6) (Figure 1), with no significant differences in the incidence of permanent pacemaker implantation, heart failure admission, stroke, bleeding o vascular complication (Figure 1).
Conclusion
Annular aortic self-expandable prothesis Portico is a feasible alternative for patients with AS and low surgical risk who undergo TAVR procedure.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Tamargo
- University Hospital Gregorio Maranon , Madrid , Spain
| | - E Gutierrez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - M E Vazquez
- University Hospital Gregorio Maranon , Madrid , Spain
| | - R Sanz-Ruiz
- University Hospital Gregorio Maranon , Madrid , Spain
| | | | - J Soriano
- University Hospital Gregorio Maranon , Madrid , Spain
| | - J Elizaga
- University Hospital Gregorio Maranon , Madrid , Spain
| | | |
Collapse
|
5
|
Viegas Madrid V, Peláez A, Sánchez A, Soriano J, Girón R. 581 UROLOGICAL SYMPTOMS IN PATIENTS WITH COVID-19: EXPLORING CHANGES IN FREQUENCY BY PANDEMIC WAVES. Continence 2022; 2:1-2. [PMID: 35822128 PMCID: PMC9263167 DOI: 10.1016/j.cont.2022.100470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Matamoros-Angles A, Hervera A, Soriano J, Martí E, Carulla P, Llorens F, Nuvolone M, Aguzzi A, Ferrer I, Gruart A, Delgado-García JM, Del Río JA. Analysis of co-isogenic prion protein deficient mice reveals behavioral deficits, learning impairment, and enhanced hippocampal excitability. BMC Biol 2022; 20:17. [PMID: 35027047 PMCID: PMC8759182 DOI: 10.1186/s12915-021-01203-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Accepted: 12/02/2021] [Indexed: 12/22/2022] Open
Abstract
Background Cellular prion protein (PrPC) is a cell surface GPI-anchored protein, usually known for its role in the pathogenesis of human and animal prionopathies. However, increasing knowledge about the participation of PrPC in prion pathogenesis contrasts with puzzling data regarding its natural physiological role. PrPC is expressed in a number of tissues, including at high levels in the nervous system, especially in neurons and glial cells, and while previous studies have established a neuroprotective role, conflicting evidence for a synaptic function has revealed both reduced and enhanced long-term potentiation, and variable observations on memory, learning, and behavior. Such evidence has been confounded by the absence of an appropriate knock-out mouse model to dissect the biological relevance of PrPC, with some functions recently shown to be misattributed to PrPC due to the presence of genetic artifacts in mouse models. Here we elucidate the role of PrPC in the hippocampal circuitry and its related functions, such as learning and memory, using a recently available strictly co-isogenic Prnp0/0 mouse model (PrnpZH3/ZH3). Results We performed behavioral and operant conditioning tests to evaluate memory and learning capabilities, with results showing decreased motility, impaired operant conditioning learning, and anxiety-related behavior in PrnpZH3/ZH3 animals. We also carried in vivo electrophysiological recordings on CA3-CA1 synapses in living behaving mice and monitored spontaneous neuronal firing and network formation in primary neuronal cultures of PrnpZH3/ZH3 vs wildtype mice. PrPC absence enhanced susceptibility to high-intensity stimulations and kainate-induced seizures. However, long-term potentiation (LTP) was not enhanced in the PrnpZH3/ZH3 hippocampus. In addition, we observed a delay in neuronal maturation and network formation in PrnpZH3/ZH3 cultures. Conclusion Our results demonstrate that PrPC promotes neuronal network formation and connectivity. PrPC mediates synaptic function and protects the synapse from excitotoxic insults. Its deletion may underlie an epileptogenic-susceptible brain that fails to perform highly cognitive-demanding tasks such as associative learning and anxiety-like behaviors. Supplementary Information The online version contains supplementary material available at 10.1186/s12915-021-01203-0.
Collapse
Affiliation(s)
- A Matamoros-Angles
- Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.,Department of Cell Biology, Physiology, and Immunology, University of Barcelona, Barcelona, Spain.,CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain.,Institute of Neuroscience, University of Barcelona, Barcelona, Spain.,Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - A Hervera
- Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.,Department of Cell Biology, Physiology, and Immunology, University of Barcelona, Barcelona, Spain.,CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain.,Institute of Neuroscience, University of Barcelona, Barcelona, Spain
| | - J Soriano
- Departament de Física de la Materia Condensada, University of Barcelona, Barcelona, Spain.,Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain
| | - E Martí
- Department of Biomedicine, University of Barcelona, Barcelona, Spain.,Bioinformatics and Genomics, Center for Genomic Regulation, Barcelona, Spain
| | - P Carulla
- Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.,Department of Cell Biology, Physiology, and Immunology, University of Barcelona, Barcelona, Spain.,CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain
| | - F Llorens
- CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain.,Department of Neurology, University Medical School, Göttingen, Germany.,Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalonia, Spain
| | - M Nuvolone
- Institute of Neuropathology, University Hospital of Zürich, Zürich, Switzerland.,Amyloidosis Center, Foundation IRCCS Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy
| | - A Aguzzi
- Institute of Neuropathology, University Hospital of Zürich, Zürich, Switzerland
| | - I Ferrer
- CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain.,Institute of Neuroscience, University of Barcelona, Barcelona, Spain.,Senior Consultant, Bellvitge University Hospital, IDIBELL (Bellvitge Biomedical Research Centre), L'Hospitalet de Llobregat, Spain.,Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain
| | - A Gruart
- Division of Neurosciences, Pablo de Olavide University, 41013, Seville, Spain
| | - J M Delgado-García
- Division of Neurosciences, Pablo de Olavide University, 41013, Seville, Spain.
| | - J A Del Río
- Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain. .,Department of Cell Biology, Physiology, and Immunology, University of Barcelona, Barcelona, Spain. .,CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Barcelona, Spain. .,Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
| |
Collapse
|
7
|
Fernández-García S, Orlandi JG, García-Díaz Barriga GA, Rodríguez MJ, Masana M, Soriano J, Alberch J. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease. BMC Biol 2020; 18:58. [PMID: 32466798 PMCID: PMC7254676 DOI: 10.1186/s12915-020-00794-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Accepted: 05/12/2020] [Indexed: 12/31/2022] Open
Abstract
Background Network alterations underlying neurodegenerative diseases often precede symptoms and functional deficits. Thus, their early identification is central for improved prognosis. In Huntington’s disease (HD), the cortico-striatal networks, involved in motor function processing, are the most compromised neural substrate. However, whether the network alterations are intrinsic of the striatum or the cortex is not fully understood. Results In order to identify early HD neural deficits, we characterized neuronal ensemble calcium activity and network topology of HD striatal and cortical cultures. We used large-scale calcium imaging combined with activity-based network inference analysis. We extracted collective activity events and inferred the topology of the neuronal network in cortical and striatal primary cultures from wild-type and R6/1 mouse model of HD. Striatal, but not cortical, HD networks displayed lower activity and a lessened ability to integrate information. GABAA receptor blockade in healthy and HD striatal cultures generated similar coordinated ensemble activity and network topology, highlighting that the excitatory component of striatal system is spared in HD. Conversely, NMDA receptor activation increased individual neuronal activity while coordinated activity became highly variable and undefined. Interestingly, by boosting NMDA activity, we rectified striatal HD network alterations. Conclusions Overall, our integrative approach highlights striatal defective network integration capacity as a major contributor of basal ganglia dysfunction in HD and suggests that increased excitatory drive may serve as a potential intervention. In addition, our work provides a valuable tool to evaluate in vitro network recovery after treatment intervention in basal ganglia disorders.
Collapse
Affiliation(s)
- S Fernández-García
- Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.,Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain
| | - J G Orlandi
- Complexity Science Group, Department of Physics and Astronomy, Faculty of Science, University of Calgary, Calgary, AB, T2N 1N4, Canada.,Departament de Física de la Matèria Condensada, Universitat de Barcelona, 08028, Barcelona, Spain
| | - G A García-Díaz Barriga
- Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.,Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain
| | - M J Rodríguez
- Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.,Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain
| | - M Masana
- Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.,Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain
| | - J Soriano
- Departament de Física de la Matèria Condensada, Universitat de Barcelona, 08028, Barcelona, Spain.,Universitat de Barcelona Institute of Complex Systems (UBICS), 08028, Barcelona, Spain
| | - J Alberch
- Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain. .,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain. .,Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain. .,Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, 08036, Barcelona, Spain.
| |
Collapse
|
8
|
Crowe JA, El-Tamer A, Nagel D, Koroleva AV, Madrid-Wolff J, Olarte OE, Sokolovsky S, Estevez-Priego E, Ludl AA, Soriano J, Loza-Alvarez P, Chichkov BN, Hill EJ, Parri HR, Rafailov EU. Development of two-photon polymerised scaffolds for optical interrogation and neurite guidance of human iPSC-derived cortical neuronal networks. Lab Chip 2020; 20:1792-1806. [PMID: 32314760 DOI: 10.1039/c9lc01209e] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Recent progress in the field of human induced pluripotent stem cells (iPSCs) has led to the efficient production of human neuronal cell models for in vitro study. This has the potential to enable the understanding of live human cellular and network function which is otherwise not possible. However, a major challenge is the generation of reproducible neural networks together with the ability to interrogate and record at the single cell level. A promising aid is the use of biomaterial scaffolds that would enable the development and guidance of neuronal networks in physiologically relevant architectures and dimensionality. The optimal scaffold material would need to be precisely fabricated with submicron resolution, be optically transparent, and biocompatible. Two-photon polymerisation (2PP) enables precise microfabrication of three-dimensional structures. In this study, we report the identification of two biomaterials that support the growth and differentiation of human iPSC-derived neural progenitors into functional neuronal networks. Furthermore, these materials can be patterned to induce alignment of neuronal processes and enable the optical interrogation of individual cells. 2PP scaffolds with tailored topographies therefore provide an effective method of producing defined in vitro human neural networks for application in influencing neurite guidance and complex network activity.
Collapse
Affiliation(s)
- J A Crowe
- School of Life and Health Sciences, Aston University, B4 7ET Birmingham, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Tamargo Delpon MA, Gutierrez E, Diez-Delhoyo F, Gonzalez-Saldivar H, Rivera AR, Casado A, Vazquez ME, Sanz R, Soriano J, Elizaga J, Fernandez-Aviles FJ. P5621Diagnostic accuracy of resting full-cycle ratio in the non-culprit artery of acute patients. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0565] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Resting full-cycle ratio (RFR) is a novel non-hyperemic index of coronary stenosis severity, independent of the timing within the cardiac cycle. Recent data has demonstrated good correlation between RFR and Fractional Flow Reserve (FFR) in stable coronary disease (SCD). However, there are no data regarding the reliability of RFR in non-culprit arteries of patients presenting with acute myocardial infarction (AMI).
Purpose
To study the diagnostic accuracy of RFR versus FFR in the non-culprit artery in AMI compared to stable lesions.
Methods
RFR, FFR, Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR), and Resistance Reserve Ratio (RRR) were calculated in 67 patients with AMI and an intermediate lesion in a non-culprit artery (median time from primary PCI to study: 48 hours). Data were compared with those of a retrospective group of 66 patients with SCD.
Results
There was a higher proportion of males among patients of the AMI group (85% vs 62%, p=0.0026). Mean age was 64.5±11 years, being AMI cohort younger at presentation [62±11 vs 67±12 years in SCD cohort (p=0.04)]. Patients with AMI had a significantly lower prevalence of hypertension (52% vs 75%, p=0.006), diabetes (10% vs 32%), p=0.002) and hyperlipemia (37% vs 79%, p=0.002).
Coronary physiology parameters showed a non-normal distribution, and are expressed as median [IQR] (Table 1). In patients with AMI, FFR was lower than in patients with SCD. In contrast, RFR showed no significant difference. Both CFR and RRR were higher in the AMI group. No significant differences in IMR were found between cohorts.
Importantly, in the AMI group the correlation between RFR and FFR was 0.84 and the overall agreement 82%, with rates of false positive and negative of 15% and 3%, respectively. In SCD the correlation was 0.81 with a lower overall agreement of 69%, due mostly to a higher rate of false positive RFR (28%) (Figure 1).
Table 1. Microcirculatory parameters in non-culprit artery (AMI) and stable coronary disease (SCD) AMI (N=66) Stable (N=67) p value FFR 0.84 [0.76–0.9] 0.84 [0.76–0.9] 0.006 RFR 0.89 [0.82–0.94] 0,9 [0.84–0.94] 0.24 CFR 2.2 [1.7–3.1] 1.8 [1.1–2.6] 0.011 IMR 17 [14–27] 25 [14–38] 0.051 RRR 2.7 [2.17 - 3.9] 2.1 [1.4–3.1] 0.005 Median [IQR].
Figure 1. Correlation between RFR and FFR valueS
Conclusions
RFR shows a good correlation with FFR in AMI. Surprisingly, overall agreement is higher in the non-culprit artery in an acute setting, with a lower percentage of false positive results.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
| | - E Gutierrez
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - F Diez-Delhoyo
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | | | - A R Rivera
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - A Casado
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - M E Vazquez
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - R Sanz
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - J Soriano
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - J Elizaga
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | | |
Collapse
|
10
|
Tamargo Delpon MA, Gutierrez Ibanes E, Diez-Delhoyo F, Gonzalez-Saldivar H, Rivera AR, Casado A, Vazquez ME, Sanz R, Soriano J, Elizaga J, Fernandez-Aviles FJ. 6115Influence of microvascular function and coronary flow in the diagnostic precision of resting full-cycle ratio. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction
Resting full-cycle ratio (RFR) has been recently described as a non-hyperemic index of coronary stenosis with good concordance with Fractional Flow Reserve (FFR). However, there is no information concerning the influence of microvascular function and coronary flow on RFR results.
Purpose
To determine if the accuracy of this novel parameter might be influenced by changes in microvascular function.
Methods
133 patients admitted in our center between July 2016 and December 2017 underwent coronary physiology study of an angiographically intermediate lesion. 67 subjects presented with AMI and an intermediate lesion in a non-culprit artery, and 66 subjects stable coronary disease. We performed FFR, Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR) and Resistance Reserve Ratio (RRR) in all of them. We calculated RFR retrospectively from the pressure tracings.
Results
Coronary physiology parameters showed a non-normal distribution and are presented as median [IQR]: FFR 0.86 [0.79–0.92]; CFR 2.05 [1.4–2.95]; IMR 20.5 [14–32.55]; RRR 2.5 [1.85–3.63]; RFR 0.897 [0.83–0.94]. Patients with abnormal CFR displayed lower RFR values although FFR was not markedly affected (Table 1). These findings remained irrespective of the clinical scenario at presentation.
61 patients had a CFR lower than 2. Correlation between RFR and FFR was not significantly different in patients with abnormal CFR than in those with normal CFR (0,73 vs 0,88; p=0,067) (Figure 1); however, overall binary agreement between RFR and FFR was worse in patients with a low CFR (69% vs 83%; p=0,047).
48 patients had a high IMR (>25). Linear correlation between RFR and FFR was similar in patients with high and normal IMR (0,81 vs 0,83; p=0,784); likewise, binary concordance showed no significant difference between both groups (77% vs 75%, p=0,78).
The mean difference between RFR and FFR was 0,025. This was only influenced by CFR: patients with a low CFR had a smaller difference than those with a normal CFR (0,012 vs 0,035; p=0,019).
Physiology parameters by CFR group Normal CFR (≥2) Low CFR (<2) P-value FFR 0.88 [0.82–0.93] 0.84 [0.79–0.92] 0.14 RFR 0.91 [0.88–0.95] 0.86 [0.80–0.92] 0.0009 IMR 16.5 [13–27] 25 [16–45.5] 0.002 RRR 3.6 [2.7–4.9] 1.7 [1.3–2.1] <0.0001 Physiological coronary parameters (Median [IQR]) according to CFR.
Correlation between RFR and FFR by CFR
Conclusion
RFR has good overall correlation and concordance with FFR. However, RFR has a lower diagnostic accuracy in patients with a low CFR.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
| | | | - F Diez-Delhoyo
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | | | - A R Rivera
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - A Casado
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - M E Vazquez
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - R Sanz
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - J Soriano
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | - J Elizaga
- University Hospital Gregorio Maranon, Cardiology, Madrid, Spain
| | | |
Collapse
|
11
|
Lima M, Jennifer V, Dominguez C, Robin G, Dunia M, Alexander O, Giselle G, Amparo M, Ivan R, Noyde B, Soriano J. Nimotuzumab bi-weekly/low dose combined to chemotherapy in advanced pancreatic cancer: A clinical study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Espí IM, Soriano J, Barrios L, Ibáñez E, Nogués C. Photochemical internalization to release microparticles entrapped in lysosomes. Photodiagnosis Photodyn Ther 2017. [DOI: 10.1016/j.pdpdt.2017.01.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Soriano J, Mora-Espí I, Alea M, Pérez-Gàrcia L, Barrios L, Ibáñez E, Nogués C. Cell death mechanisms in tumoral and non-tumoral human breast epithelial cell lines triggered by Na-H 2 TCPP or Na-ZnTCPP photodynamic treatments: Apoptosis, necrosis and parthanatos. Photodiagnosis Photodyn Ther 2017. [DOI: 10.1016/j.pdpdt.2017.01.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Soriano J, Mora-Espí I, Alea-Reyes ME, Pérez-García L, Barrios L, Ibáñez E, Nogués C. Cell Death Mechanisms in Tumoral and Non-Tumoral Human Cell Lines Triggered by Photodynamic Treatments: Apoptosis, Necrosis and Parthanatos. Sci Rep 2017; 7:41340. [PMID: 28112275 PMCID: PMC5256096 DOI: 10.1038/srep41340] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 12/16/2016] [Indexed: 12/28/2022] Open
Abstract
Cell death triggered by photodynamic therapy can occur through different mechanisms: apoptosis, necrosis or autophagy. However, recent studies have demonstrated the existence of other mechanisms with characteristics of both necrosis and apoptosis. These new cell death pathways, collectively termed regulated necrosis, include a variety of processes triggered by different stimuli. In this study, we evaluated the cell death mechanism induced by photodynamic treatments with two photosensitizers, meso-tetrakis (4-carboxyphenyl) porphyrin sodium salt (Na-H2TCPP) and its zinc derivative Na-ZnTCPP, in two human breast epithelial cell lines, a non-tumoral (MCF-10A) and a tumoral one (SKBR-3). Viability assays showed that photodynamic treatments with both photosensitizers induced a reduction in cell viability in a concentration-dependent manner and no dark toxicity was observed. The cell death mechanisms triggered were evaluated by several assays and cell line-dependent results were found. Most SKBR-3 cells died by either necrosis or apoptosis. By contrast, in MCF-10A cells, necrotic cells and another cell population with characteristics of both necrosis and apoptosis were predominant. In this latter population, cell death was PARP-dependent and translocation of AIF to the nucleus was observed in some cells. These characteristics are related with parthanatos, being the first evidence of this type of regulated necrosis in the field of photodynamic therapy.
Collapse
Affiliation(s)
- J Soriano
- Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Spain
| | - I Mora-Espí
- Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Spain
| | - M E Alea-Reyes
- Departament de Farmacologia, toxicologia i Química Terapèutica and Institut de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, Spain
| | - L Pérez-García
- Departament de Farmacologia, toxicologia i Química Terapèutica and Institut de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, Spain
| | - L Barrios
- Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Spain
| | - E Ibáñez
- Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Spain
| | - C Nogués
- Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Spain
| |
Collapse
|
15
|
Belland L, Rivera-Reyes L, Genes N, Thum F, Winkel G, Soriano J, Hwang U. EMF-226 The Effect of a Novel Clinical Decision Support System on Pain Care for Older Adults Presenting to the Emergency Department With Acute Abdominal Pain. Ann Emerg Med 2014. [DOI: 10.1016/j.annemergmed.2014.07.253] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Schmeltzer C, Soriano J, Sokolov IM, Rüdiger S. Percolation of spatially constrained Erdős-Rényi networks with degree correlations. Phys Rev E Stat Nonlin Soft Matter Phys 2014; 89:012116. [PMID: 24580181 DOI: 10.1103/physreve.89.012116] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Indexed: 06/03/2023]
Abstract
Motivated by experiments on activity in neuronal cultures [ J. Soriano, M. Rodríguez Martínez, T. Tlusty and E. Moses Proc. Natl. Acad. Sci. 105 13758 (2008)], we investigate the percolation transition and critical exponents of spatially embedded Erdős-Rényi networks with degree correlations. In our model networks, nodes are randomly distributed in a two-dimensional spatial domain, and the connection probability depends on Euclidian link length by a power law as well as on the degrees of linked nodes. Generally, spatial constraints lead to higher percolation thresholds in the sense that more links are needed to achieve global connectivity. However, degree correlations favor or do not favor percolation depending on the connectivity rules. We employ two construction methods to introduce degree correlations. In the first one, nodes stay homogeneously distributed and are connected via a distance- and degree-dependent probability. We observe that assortativity in the resulting network leads to a decrease of the percolation threshold. In the second construction methods, nodes are first spatially segregated depending on their degree and afterwards connected with a distance-dependent probability. In this segregated model, we find a threshold increase that accompanies the rising assortativity. Additionally, when the network is constructed in a disassortative way, we observe that this property has little effect on the percolation transition.
Collapse
Affiliation(s)
- C Schmeltzer
- Institut für Physik, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| | - J Soriano
- Departament d'ECM, Facultat de Física, Universitat de Barcelona, 08028 Barcelona, Spain
| | - I M Sokolov
- Institut für Physik, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| | - S Rüdiger
- Institut für Physik, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| |
Collapse
|
17
|
Speciani AF, Soriano J, Speciani MC, Piuri G. Five great food clusters of specific IgG for 44 common food antigens. A new approach to the epidemiology of food allergy. Clin Transl Allergy 2013. [PMCID: PMC3723949 DOI: 10.1186/2045-7022-3-s3-p67] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
18
|
Piuri G, Soriano J, Speciani MC, Speciani AF. B cell activating factor (BAFF) and platelet activating factor (PAF) could both be markers of non-IgE-mediated reactions. Clin Transl Allergy 2013. [PMCID: PMC3723786 DOI: 10.1186/2045-7022-3-s3-o5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
19
|
Figueras J, Lopez-Ben S, Alsina M, Soriano J, Hernandez-Yagüe X, Albiol M, Guardeño R, Codina-Barreras A, Queralt B. Preoperative treatment with bevacizumab in combination with chemotherapy in patients with unresectable metastatic colorectal carcinoma. Clin Transl Oncol 2012; 15:460-6. [PMID: 23143951 DOI: 10.1007/s12094-012-0952-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2012] [Accepted: 10/01/2012] [Indexed: 01/05/2023]
Abstract
PURPOSE This prospective observational study assessed the efficacy of bevacizumab in combination with chemotherapy as preoperative treatment to downsize tumours for radical resection in patients with unresectable metastatic colorectal cancer (mCRC). PATIENTS/METHODS Patients with mCRC initially unresectable according to predefined criteria were included. Preoperative treatment consisted of bevacizumab (5 mg/kg) combined with oxaliplatin- or irinotecan-based chemotherapy, which was followed by surgery in patients showing clinical benefit. Resection rate was the primary endpoint. Response rate (RR) and clinical benefit of preoperative chemotherapy, and overall survival (OS) were secondary endpoints. RESULTS A total of 120 eligible patients were included and received preoperative treatment. Chemotherapy was irinotecan-based in 73 (61 %) patients, oxaliplatin-based in 25 (21 %) and 22 (18 %) patients received more than one line. A RR of 30 % and a clinical benefit rate of 73 % were observed with preoperative chemotherapy. Metastatic resection was possible in 61 (51 %) patients. Median OS was 33 months (95 % CI 31-NA months) for patients undergoing surgery, and 15 months (95 % CI 11-25 months) in non-operated patients. Thirty-five patients experienced 59 postoperative complications (morbidity rate 57 %). CONCLUSION Preoperative bevacizumab-based chemotherapy offers a high surgical rescue rate in patients with initially unresectable mCRC.
Collapse
Affiliation(s)
- J Figueras
- Department of Surgery, Dr Josep Trueta Hospital, Av. de França s/n, 17007, Girona Biomedical Research Institute (IdIBGi), Girona, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Arregui FJ, Soriano J, Cabrera E, Cobacho R. Nine steps towards a better water meter management. Water Sci Technol 2012; 65:1273-1280. [PMID: 22437026 DOI: 10.2166/wst.2012.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The paper provides a comprehensive perspective of the critical aspects to be taken into account when planning the long-term management of water meters in a utility. In order to facilitate their quick understanding and practical implementation, they have been structured into nine steps. Ranging from an initial audit up to the final periodic meter replacement planning, these steps cover three aspects of the problem - field work, laboratory work and management tasks; and each one is developed in detail paying attention to the particular data needed and noting the practical outcome it will yield.
Collapse
Affiliation(s)
- F J Arregui
- Universitat Politècnica de València, Valencia, Spain.
| | | | | | | |
Collapse
|
21
|
Soriano J, Batista N, Lima M, Rodríguez R, López M, Montenegro A, Ramos M, Rodríguez L, García R, Rodríguez M. 732 POSTER Phase I clinical study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody (Nimotuzumab) in combination with chemotherapy in patients with locally-advanced breast cancer. Preliminary results. EJC Suppl 2007. [DOI: 10.1016/s1359-6349(07)70531-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
22
|
Soriano J, Pérez I, Domínguez A. Evaluación del uso de estrategias sintácticas en lectura por alumnos sordos con y sin implante coclear. ACTA ACUST UNITED AC 2006. [DOI: 10.1016/s0214-4603(06)70105-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
23
|
Soriano J, Mercier A, Planet R, Hernández-Machado A, Rodríguez MA, Ortín J. Anomalous roughening of viscous fluid fronts in spontaneous imbibition. Phys Rev Lett 2005; 95:104501. [PMID: 16196933 DOI: 10.1103/physrevlett.95.104501] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2004] [Indexed: 05/04/2023]
Abstract
We report experiments on spontaneous imbibition of a viscous fluid by a model porous medium in the absence of gravity. The average position of the interface satisfies Washburn's law. Scaling of the interface fluctuations suggests a dynamic exponent z approximately 3, indicative of global dynamics driven by capillary forces. The complete set of exponents clearly shows that interfaces are not self-affine, exhibiting distinct local and global scaling, both for time (beta = 0.64 +/- 0.02, beta(*) = 0.33 +/- 0.03) and space (alpha = 1.94 +/- 0.20, alpha(loc) = 0.94 +/- 0.10). These values are compatible with an intrinsic anomalous scaling scenario.
Collapse
Affiliation(s)
- J Soriano
- Experimentalphysik I, Universität Bayreuth, Germany
| | | | | | | | | | | |
Collapse
|
24
|
Neffen H, Fritscher C, Cuevas Schacht F, Soriano J, Mechali D. Asthma control in Latin America: The Asthma Insights and Reality in Latin America survey (AIRLA). J Allergy Clin Immunol 2005. [DOI: 10.1016/j.jaci.2004.12.703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Montiel AM, Fernández FJ, Marcial J, Soriano J, Barrios-González J, Tomasini A. A fungal phenoloxidase (tyrosinase) involved in pentachlorophenol degradation. Biotechnol Lett 2004; 26:1353-7. [PMID: 15604763 DOI: 10.1023/b:bile.0000045632.36401.86] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Amylomyces rouxii eliminated 85% of initial pentachlorophenol (PCP) at 12.5 mg l(-1) when grown with 0.1 g tyrosine l(-1), but only 55% without tyrosine. Addition of tyrosine in the culture medium increased the monophenolase activity by 1.8-fold. Tyrosinase is thus indicated to be the phenoloxidase involved in PCP degradation by A. rouxii .
Collapse
Affiliation(s)
- A M Montiel
- Depto. de Biotecnología, Univ. Autónoma Metropolitana-Iztapalala, Apdo. Postal 55-535, C.P. 09340, D.F. Mexico
| | | | | | | | | | | |
Collapse
|
26
|
Miralles JC, Negro JM, Alonso JM, García M, Sánchez-Gascón F, Soriano J. Occupational rhinitis and bronchial asthma due to TBTU and HBTU sensitization. J Investig Allergol Clin Immunol 2004; 13:133-4. [PMID: 12968399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/04/2023] Open
Abstract
Exposure to an increasing amount of products in the work environment is leading to new cases of occupational asthma among workers. We report the case of a worker at a pharmaceutical plant who developed occupational rhinitis and bronchial asthma due to HBTU: 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate and TBTU: 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate sensitization, two chemical products widely used in peptide synthesis and coupling. Skin tests (prick test) with HBTU and TBTU solutions in PBS were positive at a concentration of 1 mg/ml. Skin tests with the same solutions in 10 atopic controls yielded a negative result. Nasal challenge tests with these products were positive with HBTU at a concentration of 0.01 mg/ml and TBTU at a concentration of 1 mg/ml. In both cases PNIF (peak nasal inspiratory flow) decreased by more than 60% and severe sneezing and rhinorrhea were induced. Nasal challenge tests performed on 10 atopic controls with TBTU and HBTU at a concentration of 1 mg/ml were negative. We conclude that the patient presents occupational rhinitis and bronchial asthma due to TBTU and HBTU; the operational mechanism is probably immunological IgE-mediated given the positive prick tests and nasal challenge with these products.
Collapse
Affiliation(s)
- J C Miralles
- Allergy Section, University General Hospital, Murcia, Spain.
| | | | | | | | | | | |
Collapse
|
27
|
Fuentes JA, Lauzurica N, Hurtado A, Escartí A, Barrios V, Morandé G, Soriano J, Jáuregui I, González-Valdemoro MI, García-Camba E. Analysis of the −1438 G/A polymorphism of the 5-HT2A serotonin receptor gene in bulimia nervosa patients with or without a history of anorexia nervosa. Psychiatr Genet 2004; 14:107-9. [PMID: 15167698 DOI: 10.1097/01.ypg.0000107933.32051.55] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
A single nucleotide polymorphism (-1438 G/A) located 1438 base pairs upstream of the consensus start site of the 5-HT2A receptor gene has been reported. The hypothesis that this gene polymorphism may be a susceptibility factor in bulimia nervosa was explored in a female population of purgative bulimics. Bulimia nervosa patients who have suffered preceding anorexia nervosa episodes formed the so-called previous anorexia nervosa bulimic patient group. At variance with some previous reports, when the frequency distribution of genotypes and alleles was compared in patients and controls, no differences were detected regardless of whether the bulimia nervosa patients had suffered prior anorexia nervosa episodes.
Collapse
Affiliation(s)
- J A Fuentes
- Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Lauzurica N, Hurtado A, Escartí A, Delgado M, Barrios V, Morandé G, Soriano J, Jáuregui I, González-Valdemoro MI, García-Camba E, Fuentes JA. Polymorphisms within the promoter and the intron 2 of the serotonin transporter gene in a population of bulimic patients. Neurosci Lett 2003; 352:226-30. [PMID: 14625025 DOI: 10.1016/j.neulet.2003.08.058] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The serotonin transporter (5-HTT) gene is a firm candidate to explain eating disorders. In this association study, two different polymorphisms were analysed: a variable number of tandem repeat (VNTR) polymorphism in intron 2 and a deletion/insertion polymorphism (5-HTTLPR) in the promoter region. The hypothesis that these gene polymorphisms may be a susceptibility factor in bulimia nervosa (BN) was explored in a female population of 102 purgative bulimics. BN patients who have suffered preceding anorexia nervosa (AN) episodes formed the so-called previous AN bulimic patient group. In our sample of normal-eater controls and purging type bulimics, regardless of whether or not the BN patients had suffered prior AN episodes, no differences were found considering the frequencies of genotypes, alleles or haplotypes of both polymorphic regions of the 5-HTT gene.
Collapse
Affiliation(s)
- N Lauzurica
- Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, Avenida Juan XXIII 1, 28040, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Rennard S, Decramer M, Calverley P, Pride N, Soriano J, Vermeire P, Vestbo J. Impacto da DPOC na América do Norte e na Europa em 2000: a perspectiva dos indivíduos na Avaliação Internacional de Confrontar a DPOC. Revista Portuguesa de Pneumologia 2003. [DOI: 10.1016/s0873-2159(15)30697-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
30
|
Abstract
There is a strong evidence to suggest the association between breast cancer and diffuse scleroderma, though it is an infrequent occurrence. We describe the clinical and radiological findings in a patient who, over a period of 2 years, was diagnosed initially of diffuse scleroderma, next with right breast cancer and finally with left breast cancer. A review of the literature evidencing the relation between these two pathologies is provided. We suggest that special vigilance for tumoral pathology of the breast should be performed in patients with systemic scleroderma.
Collapse
Affiliation(s)
- V Pineda
- Radiology Department, Vall d'Hebron General Hospital, Autonomous University of Barcelona, Barcelona, Spain.
| | | | | |
Collapse
|
31
|
Granell M, Peña J, Ubeda J, Soriano J, Tatay J, Cantó A, Llorens J. [Anesthesiology alternatives for lobectomy with thoracotomy in a patient with allergy to multiple neuromuscular blockers]. Rev Esp Anestesiol Reanim 2003; 50:160-2. [PMID: 12708217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
|
32
|
Soriano J, Ramasco JJ, Rodríguez MA, Hernández-Machado A, Ortín J. Anomalous roughening of Hele-Shaw flows with quenched disorder. Phys Rev Lett 2002; 89:026102. [PMID: 12097009 DOI: 10.1103/physrevlett.89.026102] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/07/2001] [Indexed: 05/23/2023]
Abstract
The kinetic roughening of a stable oil-air interface moving in a Hele-Shaw cell that contains a quenched columnar disorder (tracks) has been studied. A capillary effect is responsible for the dynamic evolution of the resulting rough interface, which exhibits anomalous scaling. The three independent exponents needed to characterize the anomalous scaling are determined experimentally. The anomalous scaling is explained in terms of the initial acceleration and subsequent deceleration of the interface tips in the tracks coupled by mass conservation. A phenomenological model that reproduces the measured global and local exponents is introduced.
Collapse
Affiliation(s)
- J Soriano
- Departament ECM, Facultat de Física, Universitat de Barcelona, Diagonal 647, E-08028 Barcelona, Spain
| | | | | | | | | |
Collapse
|
33
|
|
34
|
Abstract
BACKGROUND There is growing evidence that some cases of chronic urticaria and angioedema are associated with thyroid autoimmunity. We present the case of a 42-year old woman with a two month long evolution of edema in the right hemiface associated with thyroid antibodies. METHODS Skin tests were performed with a standard series of aeroallergens and foods and were negative. Epicutaneous tests were performed with a series of contact allergens with a negative result. The chest X-ray was normal. A complete blood count was performed with ESR, biochemistry study, proteinogram, coagulation, complement, rheumatoid factor, anti-nuclear antibodies, hydatidosis and hepatitis serologies, urine sediment and stool parasitology, which were normal. The TSH was normal and, among the thyroid antibodies, the thyroglobulin ones (492 IU/mL) were positive and the microsomal ones were negative. RESULTS The edema remitted with the 2-month long thyroxin treatment. In spite of the clinical response, and although the thyroglobulin antibodies initially suffered a small decrease, they increased to values which greatly surpassed the initial ones, coinciding with a relapse of the facial edema, so that treatment was re-initiated with thyroxin, and the picture subsided again. CONCLUSIONS Some cases of localized edema can be associated with thyroid antibodies and respond to treatment with thyroxin.
Collapse
Affiliation(s)
- J C Miralles
- Allergy Section. University General Hospital of Murcia. Spain
| | | | | |
Collapse
|
35
|
Soriano J, Salvador R, Pineda V, Sánchez M. Fribrohistiocitoma maligno de la mama: presentación de un caso y revisión bibliográfica. Cir Esp 2002. [DOI: 10.1016/s0009-739x(02)72005-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Soriano J. [The "Jumpstart" treatment adherence program]. Sidahora 2001:14-6. [PMID: 11681261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
|
37
|
Durán MA, Carbajal-De Nova D, Carrera E, Soriano J. Extraskeletical malformations in the Jarcho-Levin syndrome: postmortem study of three cases. Pediatr Pathol Mol Med 2001; 20:197-202. [PMID: 11486350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
We report on pathologic examination of three autopsied newborns with Jarcho-Levin syndrome. The most important abnormalities noted were multiple extraskeletical defects such as cardiovascular, urogenital, respiratory, and central nervous system malformations. These cases add new information to the multiple vertebral segmentation defects found in this syndrome.
Collapse
Affiliation(s)
- M A Durán
- Unidad de Anatomía Patológica del Hospital General de México and Facultad de Medicina de la UNAM, Mexico City.
| | | | | | | |
Collapse
|
38
|
Moreno R, García E, Pérez de Isla L, Acosta J, Abeytua M, Soriano J, López-Sendón JL. [In-hospital major complications associated with rotational atherectomy: experience with 800 patients at a single center]. Rev Esp Cardiol 2001; 54:460-8. [PMID: 11282051 DOI: 10.1016/s0300-8932(01)76334-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Rotational atherectomy is usually performed in patients with angiographically determined high risk coronary lesions. The aim of this study was to evaluate the rate of major adverse cardiac events (death, Q-wave infarction or new revascularization) after rotational atherectomy, as well as to identify the clinical characteristics associated with this incidence. PATIENTS AND METHODS The study population included 800 patients treated with rotational atherectomy from 1993 to 1999: 512 (64%), for de novo lesions, and 288 (36%) for restenosis. Balloon dilation and coronary stenting was performed in 95% and 34% of patients, respectively. RESULTS During hospitalization, 17 patients (2.1%) died, 16 (2%) had a Q-wave infarction, 30 (3.8%) a non-Q infarction, and new revascularization was performed in 28 (3.5%). The incidence of major adverse cardiac events was 6.5% (n = 52), this incidence being higher in the presence of diabetes (8.9 vs. 4.4%; p = 0.01), unstable angina or acute/recent myocardial infarction (7.6 vs. 3.3%; p = 0.02), multivessel disease (8.6 vs. 3.3%; p < 0.01), treated vessel other than right coronary (7.0 vs. 1.7%; p = 0.01), procedure in > 1 vessel (10.7 vs. 4.7%; p < 0.01), angiographic failure (62.5 vs. 5.5%; p < 0.001), and de novo lesions (8.4 vs. 2.5%; p < 0.01), with diabetes and treatment of de novo lesions being independent predictors of major adverse cardiac events. However, age, previous infarction, and left ventricular dysfunction, were not associated with the rate of events. CONCLUSION Some simple variables are associated with a higher incidence of major adverse cardiac events after rotational atherectomy. Advanced age, previous infarction and left ventricular dysfunction, however, do not necessarily imply a poorer prognosis in these patients.
Collapse
Affiliation(s)
- R Moreno
- Servicio de Cardiología, Hospital Gregorio Marañón, Madrid
| | | | | | | | | | | | | |
Collapse
|
39
|
Moreno R, García E, Soriano J, Acosta J, Abeytua M. Long-term outcome of patients with proximal left anterior descending coronary artery in-stent restenosis treated with rotational atherectomy. Catheter Cardiovasc Interv 2001; 52:435-42. [PMID: 11285595 DOI: 10.1002/ccd.1098] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Once a first interventional procedure has failed, patients with proximal left anterior descending in-stent restenosis are frequently sent for surgical revascularization. Data on long-term outcome in selected patients with proximal left anterior descending in-stent restenosis treated with RA are lacking. The study's objective was to evaluate the long-term outcome of patients with proximal left anterior descending artery in-stent restenosis treated with rotational atherectomy. The study population is constituted by 42 patients with proximal left anterior descending in-stent restenosis treated with rotational atherectomy. Patients were followed up for 2.1 +/- 0.9 years (range, 6--54). Restenosis length was 16.5 +/- 9.2 mm, and restenosis was diffuse (> 10 mm in length) in 30 (71.4%). The rotational atherectomy procedure was guided by intravascular ultrasound in 18 patients (42.9%). Maximum burr/artery ratio was > 0.7 in 24 (57.1%) patients. One patient suffered a periprocedural non--Q-wave infarction, but no deaths, Q-wave infarction, or new target vessel revascularization occurred during hospitalization. There were no deaths or myocardial infarctions after discharge. Sixteen patients (38.1%) needed a new revascularization, but only five (11.9%) underwent coronary bypass grafting at the end of the follow-up (2.1 +/- 0.9 years). The rate of surgical revascularization at 6 months, 1 year, and 3 years was 4.8%, 7.4%, and 18.4%, respectively. The rate of new target vessel revascularization at 6 months, 1 year, and 3 years was 16.7%, 36.5%, and 40.5%, respectively. Patients with < or = 5 months since stent implantation had a significantly higher rate of new target vessel revascularization. Patients with proximal left anterior descending in-stent restenosis may be safely treated with rotational atherectomy. This strategy is associated with a very good long-term outcome, with few patients undergoing surgical revascularization.
Collapse
Affiliation(s)
- R Moreno
- Division of Interventional Cardiology, University Hospital Gregorio Marañón, Madrid, Spain
| | | | | | | | | |
Collapse
|
40
|
Moreno R, García E, Soriano J, Abeytua M, López de Sá E, Acosta J, Péerez de Isla L, Rubio R, López-Sendon JL. Early coronary angioplasty for acute myocardial infarction: predictors of poor outcome in a non-selected population. J Invasive Cardiol 2001; 13:202-10. [PMID: 11231645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
AIMS The objective of this study was to report the experience in the treatment of acute myocardial infarction (AMI) with early coronary angioplasty (PTCA) in a single European center during one decade, attempting to identify the characteristics associated with a poor prognosis in these patients. METHODS AND RESULTS Eight hundred patients with AMI were treated with PTCA < 12 hours after symptom onset. Mean age was 64 +/- 13 years, 12% were in cardiogenic shock, AMI location was anterior in 61% and PTCA was performed after failed thrombolysis in 5%. Coronary stents and abciximab were used in 51% and 10%, respectively. An angiographic successful result was obtained in 93%, and final TIMI flow grade 3 was achieved in 83%. The overall in-hospital mortality rate was 12.5% (2.7%, 16.1%, 25.7% and 63.8% in patients in Killip class I, II, III and IV, respectively). Over the years, an improvement in the angiographic results and a reduction in the rates of reinfarction and target vessel revascularization were observed. The independent predictors of death were age > 70 years, absence of hyper-cholesterolemia, anterior location, cardiogenic shock, multi-vessel disease and unsuccessful PTCA. The leading causes of mortality were cardiogenic shock (63%) and ventricular free wall rupture (14%). The rates of non-fatal reinfarction, documented reocclusion and in-hospital repeated revascularization were 2%, 3% and 4%, respectively. CONCLUSION In most cases, PTCA performed in a non-selected patient population with AMI results in angiographic success. Mortality especially occurs in patients who are in cardiogenic shock at the beginning of the procedure. We have observed an improvement in the results throughout the course of the decade.
Collapse
Affiliation(s)
- R Moreno
- Cardiology Department, University General Hospital Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Pickens RW, Preston KL, Miles DR, Gupman AE, Johnson EO, Newlin DB, Soriano J, van den Bree MB, Umbricht A. Family history influence on drug abuse severity and treatment outcome. Drug Alcohol Depend 2001; 61:261-70. [PMID: 11164690 DOI: 10.1016/s0376-8716(00)00146-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Influence of parental alcohol/substance abuse on methadone maintenance therapy (MMT) outcome was examined in 164 DSM-III-R opioid dependent adults with no other current DSM Axis I disorder. Family history positive patients had more DSM-III-R opioid dependence symptoms and were more likely to be classified as severely dependent. However, when placed on identical daily doses of methadone (50 mg), they had lower rates of illicit opioid use but higher rates of cocaine use than family history negative patients. Both effects remained significant after adjusting for gender and race. These results suggest that common genetic factors may underlie both susceptibility to heroin dependence and response to therapeutic methadone treatment.
Collapse
Affiliation(s)
- R W Pickens
- Clinical Neurogenetics Section and Treatment Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Moreno R, Garcia E, Abeytua M, Soriano J, Acosta J, Perez De Isla L, Lopez De Sa E, Rubio R, Lopez-Sendon J. Early coronary angioplasty for acute myocardial infarction complicated by cardiogenic shock: have novel therapies led to better results? J Invasive Cardiol 2000; 12:597-604. [PMID: 11103025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Patients with acute myocardial infarction (MI) and cardiogenic shock constitute a very high risk subset despite an aggressive management. The objective of this study was to evaluate if the results of early coronary angioplasty in patients with acute myocardial infarction and cardiogenic shock have changed over the last years, and to address which role the recent adjuvant therapies have played in this evolution. From 1991 to April 1999, 94 patients with acute MI and cardiogenic shock were treated with coronary angioplasty within the first 12 hours from the onset of symptoms. Temporal changes of the utilization of adjuvant therapies and operators experience were studied over these years, as well as their impact on the angiographic results and in-hospital outcome. Over the years, a progressive and significant increase on the use of coronary stents and c7E3Fab was observed, as well as an increased number of primary angioplasties performed per month. The proportion of patients treated with intraaortic balloon pump did not changed significantly over the years. An angiographic successful result (< 50% residual stenosis and TIMI flow 2 or 3) and a final TIMI grade 3 flow were obtained in 76 (80.9%) and 61 (64.9%) patients, respectively. The angiographic success rate progressively increased over the years, from 72.3% in patients treated before 1994 to 94.1% in those admitted in 1998Eth 1999 (p for trend 0.0409). The proportion of patients with a final TIMI grade 3 flow also grew progressively over the years: from 36.4% before 1994 to 76.5% after 1997 (p for trend 0. 0209). The overall in-hospital mortality rate was 63.8% (60 patients), and there was no significant change in mortality rate over the years. Therefore, apart from the growing operators experience, we have observed an incremental change in the use of coronary stents and c7E3 Fab (abciximab) in patients with acute myocardial infarction and cardiogenic shock treated with early coronary angioplasty. All these factors have led to an improvement in the angiographic results, although this change has not meant a significant reduction of mortality.
Collapse
Affiliation(s)
- R Moreno
- Division of Interventional Cardiology, Hospital Gregorio Maranon, Doctor Esquerdo, 46, 28007, Madrid, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Abstract
The results of the Spanish Registry of Hemodynamic and Interventional Cardiology in 1999 are presented. The activity of 90 centers representing all the cardiac catheterization laboratories in Spain is reported, with 83 centers performing mainly adult cardiac catheterization and 7 centers exclusively carrying out pediatric cardiac catheterization. In 1999, a total of 82,805 diagnostic catheterization procedures, 79% being coronary angiographies (65,234; 1,637 per million inhabitants), were performed, representing a total increase of 11.4% compared to 1998. Compared to 1998, coronary intervention increased by 14.2%, with a total number of 23,010 procedures. The ratio of coronary interventions per million inhabitants was 590. Success rates for coronary interventions (94%) and complications (2.2%) were similar to those registered in previous years, and in 12.4% of the cases IIb-IIIa glycoprotein inhibitors were used. Ten point two per cent of the procedures were performed to treat acute myocardial infarction. Coronary stenting is the main device for coronary intervention. In 1999, coronary stents were used in 17,783 cases (23% increase compared to 1998), representing 77.3% of all coronary revascularization procedures. A total of 22,946 prostheses were implanted, 87% electively and 21.4% as a primary stenting procedure, with a low rate of complications (0.85% subacute closure, 1.95% myocardial infarction and 0.9% mortality). Compared to 1998, both directional coronary atherectomy (52 procedures) and rotational atherectomy (473 procedures) showed a slight decrease.A slight increase (4% compared to 1998) was reported in adult valvuloplasties (525 vs 505)while pediatric interventional procedures increased by 21% (678 vs 557 procedures) compared to 1998. In conclusion, we would like to underline the high degree of laboratory participation in the Registry, and despite the increase in activity, the current rates remain lower than European figures.
Collapse
Affiliation(s)
- J Soriano
- Sección de Hemodinámica y Cardiología Intervencionista. Sociedad Española de Cardiología
| | | | | | | |
Collapse
|
44
|
Moreno R, García E, Soriano J, Abeytua M, Martínez-Sellés M, Acosta J, Elízaga J, Botas J, Rubio R, López de Sá E, López-Sendón JL, Delcán JL. [Coronary angioplasty in the acute myocardial infarction: in which patients is it less likely to obtain an adequate coronary reperfusion?]. Rev Esp Cardiol 2000; 53:1169-76. [PMID: 10978231 DOI: 10.1016/s0300-8932(00)75221-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION In patients with acute myocardial infarction treated with primary angioplasty, the inability to achieve successful coronary reperfusion is associated with higher mortality. The objective of the study was to identify which characteristics may predict a lower angiographic success rate in patients with acute myocardial infarction treated with coronary angioplasty. PATIENTS AND METHODS The study population is constituted by the 790 patients with acute myocardial infarction that were treated with angioplasty within the 12 hours after the onset of symptoms from 1991 to 1999 at our institution. A successful angiographic result was considered in presence of a residual stenosis < 50% and a TIMI flow 2 or 3 after the procedure. RESULTS A successful angiographic result and a final TIMI 3 flow were achieved in 736 (93.2%) and 652 (82.5%) patients, respectively. In-hospital mortality was higher in patients with angiographic failure than in those with angiographic successful result (48 vs. 10%; p < 0.01). Age under 65 (91 vs. 95%; p = 0.02), non smoking (90 vs. 96%; p < 0,01), previous infarction (87 vs. 94%; p < 0.01), angioplasty after failed thrombolysis (83 vs. 94%; p = 0. 02), cardiogenic shock (80 vs. 95%; p < 0.01), undetermined location (67 vs. 93%; p < 0.01), non-inferior location (92 vs. 96%; p = 0.04), left bundle branch block (64 vs. 94%; p < 0.01), multivessel disease (91 vs. 95%; p = 0.02), left ventricular ejection fraction < 0.40 (89 vs. 97%; p < 0.01), no utilization of coronary stenting (90 vs. 96%; p < 0.01), and use of intraaortic balloon counterpulsation pump (82 vs. 95%; p < 0.01) were associated with a lower angiographic success rate. In the multivariable analysis, the following were independent predictors for angiographic failure: left bundle branch block (odds ratio [OR], 12.95; CI 95%, 3.00-53.90), cardiogenic shock (OR, 4.20; CI 95%, 1.95-8.75), no utilization of coronary stent (OR, 3.44; CI 95%, 1.71-7.37), and previous infarction (OR, 2.82; CI 95%, 1.29-5.90). CONCLUSIONS Coronary angioplasty allows a successful coronary recanalization in most patients with acute myocardial infarction. Some basic characteristics, however, may identify some subsets in which a successful angiographic result may be more difficult to obtain.
Collapse
Affiliation(s)
- R Moreno
- Departamento de Cardiología. Hospital Gregorio Marañón. Madrid
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Moreno R, López de Sá E, López-Sendón JL, García E, Soriano J, Abeytua M, Elízaga J, Botas J, Rubio R, Moreno M, García-Fernández MA, Delcán JL. Frequency of left ventricular free-wall rupture in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2000; 85:757-60, A8. [PMID: 12000054 DOI: 10.1016/s0002-9149(99)00855-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A total of 590 patients with myocardial infarction treated with primary angioplasty were studied, to assess the incidence and related factors of free-wall rupture in patients with acute myocardial infarction when treated with primary angioplasty. The incidence of free-wall rupture was 2.2% (13 patients); this incidence was higher in patients >65 years old, women, nonsmokers, as well as in those with anterior location and an initial TIMI grade 0 flow, but it was similar in patients with a successful or unsuccessful angiographic result.
Collapse
Affiliation(s)
- R Moreno
- Department of Cardiology, Hospital Universitario Gregorio Marañón, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Sunyer J, Soriano J, Antó JM, Burgos F, Pereira A, Payo F, Martínez-Moratalla J, Ramos J. Sensitization to individual allergens as risk factors for lower FEV1 in young adults. European Community Respiratory Health Survey. Int J Epidemiol 2000; 29:125-30. [PMID: 10750614 DOI: 10.1093/ije/29.1.125] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Atopy may impair ventilatory function, but results are controversial. We assess the association between individual reactivity to allergens and the level of baseline maximal one-second forced expiratory volume (FEV1), by smoking and respiratory symptoms. METHODS The 1472 participants (response 44.5%) of the five Spanish areas of the European Community Respiratory Health Survey (ECRHS) who performed respiratory function tests, skin prick tests and/or specific IgE against common aeroallergens (e.g. mites, pets, mould, pollens) are included. Bronchial hyperreactivity (BHR) was measured with a methacholine challenge. RESULTS After adjusting for BHR and smoking, in addition to the other allergens, skin reactivity to Alternaria (-208 ml; 95% CI :-451, 35) and IgE antibodies against cat (-124 ml; 95% CI:-269, 21) and Timothy grass (-115 ml, 95% CI:-190, -40) were associated with a decrease in FEV1 in females. Among males, skin reactivity to olive showed the strongest association (-111 ml; 95% CI: -261, 38). The associations were stronger in females. Smoking modifies the association for Alternaria and cat (P for interaction < 0.05). While cat is associated with a decrease in FEV1 in current smokers (-190 ml), Alternaria (-336 ml) was associated among never smokers. The exclusion of subjects with asthma symptoms, or adjustment for respiratory symptoms, led to similar results. CONCLUSIONS We conclude that immunoresponse to individual allergens (particularly outdoor) is associated with the level of FEV1, and this association occurred independently of asthma, and in smokers and non-smokers, which may be of interest in natural history of chronic obstructive pulmonary disease (COPD).
Collapse
Affiliation(s)
- J Sunyer
- Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigació Mèdica, Barcelona, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Escamilla ML, Valdés SE, Soriano J, Tomasini A. Effect of some nutritional and environmental parameters on the production of diacetyl and on starch consumption by Pediococcus pentosaceus and Lactobacillus acidophilus in submerged cultures. J Appl Microbiol 2000; 88:142-53. [PMID: 10735253 DOI: 10.1046/j.1365-2672.2000.00934.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Three series of 5-day submerged cultures with Pediococcus pentosaceus MITJ-10 and Lactobacillus acidophilus Hansen 1748 were carried out in starch-based media, and the effect of cultural factors on the changes of starch, diacetyl and amylase activity determined. In axenic cultures, Ped. pentosaceus MITJ-10 produced more diacetyl (63.27 mg l(-1)) by adding glucose, yeast extract and CaCO3 (P < 0.01), at 28 degrees C (P < 0.05); but more starch was consumed (18.4 g l(-1)) in the absence of glucose (P < 0.01). Lact. acidophilus Hansen 1748 consumed more starch (26.56 g l(-1)) at 28 degrees C, with CaCO3, glucose (P < 0.01) and yeast extract (P < 0.05); however, the amylolytic activity (10077U l(-1)) was favoured at 35 degrees C (P < 0.01). Little starch was consumed in mixed cultures due to the low pH; nevertheless, diacetyl content rose to 135.76 mg l(-1) at 32 degrees C (P < 0.01). Therefore, both studied strains might be useful to produce aromatic extensors from starchy substrates. These natural aromatic extensors are of interest to the food industry.
Collapse
Affiliation(s)
- M L Escamilla
- Depto. Biotecnología, University of Autónoma Metropolitana-Iztapalapa, Mexico City, México.
| | | | | | | |
Collapse
|
48
|
Moreno R, García E, Soriano J, Abeytua M, Elízaga J, Botas J, López Sendón JL, Delcán JL. [Results of coronary stenting in acute myocardial infarction]. Rev Esp Cardiol 2000; 53:27-34. [PMID: 10701320 DOI: 10.1016/s0300-8932(00)75060-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To describe the angiographic results and the in-hospital clinical outcome of patients with an acute phase of myocardial infarction treated with coronary angioplasty and stent placement. METHODS 268 patients with myocardial infarction were treated with angioplasty and coronary stenting within in our center 12 hours after the onset of symptoms from January in 1992 to March 1998. 366 stents were placed (1.4 +/- 0.7 per patient), 35% being Palmaz-Schatz, 26% Wiktor, 21% Multi-Link and 18% others. Stenting was elective in 171 patients (64%), and the majority of patients (91%) were treated with aspirin plus ticlopidine. RESULTS A successful angiographic result was achieved in 258 patients (96%). Minimum lumen diameter was increased from 0.2 +/- 0.3 to 2.7 +/- 0.7 mm (p < 0.001), and stenosis decreased from 94 +/- 8% to 13 +/- 11% (p < 0.001). Mortality was 15.3% (3.2%, 24.4% and 67.7% in patients in Killip class I, II-III and IV, respectively). Nonfatal reinfarction and recurrent ischemia rates were 2.6% and 9%, respectively. Stent thrombosis occurred in 8 patients (3.0%), and new target vessel revascularization was needed in 12 (4.5%). CONCLUSIONS Stent placement in acute myocardial infarction is associated with high angiographic success rate, as well as a good in-hospital outcome. Mortality is localized, especially in patients with cardiac failure at the beginning of the procedure.
Collapse
Affiliation(s)
- R Moreno
- Departamento de Cardiología, Hospital Gregorio Marañón, Madrid
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 1999; 156:1931-7. [PMID: 10588407 DOI: 10.1176/ajp.156.12.1931] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVE Despite the increasing recognition of attention deficit hyperactivity disorder (ADHD) in adults, there is a paucity of controlled pharmacological trials. Recent reports have suggested the potential usefulness of cholinergic agents for ADHD. To this end, the authors completed a controlled study of ABT-418, a novel cholinergic activating agent, for the treatment of adults with ADHD. METHOD This was a double-blind, placebo-controlled, randomized, crossover trial that compared a transdermal patch of ABT-418 (75 mg/day) to placebo in adults who met DSM-IV criteria for ADHD. There were two 3-week treatment periods separated by 1 week of washout. RESULTS Of the 32 subjects enrolled in the study (88% were men; mean age = 40 years, SD = 9), 29 completed the study. At the endpoint of each active arm (last observation carried forward), a significantly higher proportion of subjects was considered improved while receiving ABT-418 than while receiving placebo (40% versus 13%). Similarly, at endpoint there was a significantly greater reduction in ADHD symptom checklist scores (28% versus 15%). Symptoms reflective of attention, and subjects with less severe ADHD, responded more robustly to ABT-418. Treatment with ABT-418 was relatively well tolerated; dizziness and nausea were the most frequently reported adverse effects. CONCLUSIONS The results of this investigation indicate that ABT-418, a nicotinic analog, may be a potentially useful agent for the treatment of ADHD.
Collapse
Affiliation(s)
- T E Wilens
- Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Soriano J, Alfonso F, Cequier A, Morís C. [The Registry of the Activities of the Hemodynamics and Interventional Cardiology Section in 1998]. Rev Esp Cardiol 1999; 52:1105-20. [PMID: 10659656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
The results of the Spanish Registry of Hemodynamic and Interventional Cardiology of the Spanish Society of Cardiology in 1998 are hereby presented. The Registry collects the activity of 82 centers, which constitutes all the cardiac catheterization laboratories in Spain. The main activity was adult cardiac catheterization in 75 centers, and exclusively pediatric cardiac catheterization in 7. A total of 74,364 diagnostic catheterization procedures, 80% coronary angiographies (59,321; 1,498 per million inhabitants), were performed, which represents a 2.8% total increase compared to 1997. Coronary intervention increased by 8.6% compared to 1997, for a total number of 20,146 procedures. The ratio of coronary interventions per million inhabitants was 509. Success rates of coronary interventions (94%) and complications (2.3%) are similar to those registered in previous years, and in 9.7% of the cases, IIb-IIIa glicoprotein inhibitors were used. A 8.6% of the procedures were performed in order to treat an acute myocardial infarction. Coronary stenting is, continues to be the main device for coronary intervention. In 1998, coronary stents were employed in 14,497 cases (a 27% increase compared to 1997) which represents the 72% of all coronary revascularizations procedures. A total of 19,378 prosthesis were implanted, 83% in a elective way and 12.9% primary stenting, with a low rate of complications (1.5% subacute closure, 1.5% myocardial infarction and 0.94% mortality). Compared to 1997, directional coronary atherectomy (83 procedures) showed a slight decrease, whereas rotational atherectomy (549 procedures) has stabilized the number of procedures and centers performing this technique. As in previous years, a slight decrease (9% compared to 1997) in adult valvuloplasties (505 vs 559) were noted. Pediatric interventional procedures increased by 20% (557 vs 465 procedures) compared to the 1997 Registry.
Collapse
Affiliation(s)
- J Soriano
- Sección de Hemodinámica, Hospital General Universitario Gregorio Marañón, Madrid
| | | | | | | |
Collapse
|